Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Mondello

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Leukemia|July 19, 2024
Silencing GNAS enhances HDAC3i efficacy in CREBBP wild type B cell lymphomaPatrizia Mondello
Expert Review of Anticancer Therapy|February 6, 2015
Emerging drugs for diffuse large B-cell lymphomaPatrizia Mondello, Anas Younes
Hematology. American Society of Hematology. Education Program|December 7, 2024
The POD24 challenge: where do we go from here for early progressors?Patrizia Mondello, Carla Casulo
Hematological Oncology|April 3, 2019
Frontline treatment of diffuse large B-cell lymphoma: Beyond R-CHOPPatrizia Mondello, Michael Mian
Cancer Cell|November 5, 2021
PHOENIX rises: Genomic-based therapies for diffuse large B cell lymphomaPatrizia Mondello, Stephen M Ansell
Journal of Clinical Medicine|October 14, 2022
Harnessing the Molecular Fingerprints of B Cell Lymphoma for Precision TherapyAfua Adjeiwaa Mensah, Patrizia Mondello
Cancer Cell|August 22, 2025
Unraveling lymphoma-induced immune senescencePatrizia Mondello, Stephen M Ansell
Current Hematologic Malignancy Reports|May 7, 2020
Treatment of Aggressive B Cell Lymphomas: Updates in 2019Patrizia Mondello, Grzegorz S Nowakowski
Expert Opinion on Pharmacotherapy|December 14, 2021
Tazemetostat: a treatment option for relapsed/refractory follicular lymphomaPatrizia Mondello, Stephen M Ansell
British Journal of Haematology|August 8, 2020
Reshaping the therapeutic landscape of chronic lymphocytic leukaemia in the era of targeted therapyPatrizia Mondello, Andrew D Zelenetz
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Leukemia|July 19, 2024
Silencing GNAS enhances HDAC3i efficacy in CREBBP wild type B cell lymphomaPatrizia Mondello
Expert Review of Anticancer Therapy|February 6, 2015
Emerging drugs for diffuse large B-cell lymphomaPatrizia Mondello, Anas Younes
Hematology. American Society of Hematology. Education Program|December 7, 2024
The POD24 challenge: where do we go from here for early progressors?Patrizia Mondello, Carla Casulo
Hematological Oncology|April 3, 2019
Frontline treatment of diffuse large B-cell lymphoma: Beyond R-CHOPPatrizia Mondello, Michael Mian
Cancer Cell|November 5, 2021
PHOENIX rises: Genomic-based therapies for diffuse large B cell lymphomaPatrizia Mondello, Stephen M Ansell
Journal of Clinical Medicine|October 14, 2022
Harnessing the Molecular Fingerprints of B Cell Lymphoma for Precision TherapyAfua Adjeiwaa Mensah, Patrizia Mondello
Cancer Cell|August 22, 2025
Unraveling lymphoma-induced immune senescencePatrizia Mondello, Stephen M Ansell
Current Hematologic Malignancy Reports|May 7, 2020
Treatment of Aggressive B Cell Lymphomas: Updates in 2019Patrizia Mondello, Grzegorz S Nowakowski
Expert Opinion on Pharmacotherapy|December 14, 2021
Tazemetostat: a treatment option for relapsed/refractory follicular lymphomaPatrizia Mondello, Stephen M Ansell
British Journal of Haematology|August 8, 2020
Reshaping the therapeutic landscape of chronic lymphocytic leukaemia in the era of targeted therapyPatrizia Mondello, Andrew D Zelenetz
Pageof 10